Join the Oncology Voice Network. Join for Free
Season 2, Episode 6: Mentorship and Career Growth with Josh Schwartz

Season 2, Episode 6: Mentorship and Career Growth with Josh Schwartz


Share This Article


Welcome back to another fantastic episode of the Pharmaverse podcast!

This week our host Michael Pietrack interviews Josh Schwartz, MD MBA, Vice President of Medical Affairs North America at BeOne ( formerly BeiGene.) They discuss the importance of leadership in the pharmaceutical industry, focusing on developing others, the journey from individual contributor to manager, and the qualities that make an effective leader. Schwartz shares insights on mentorship, the coaching tree concept, and the five Cs of leadership: caring, communication, culture, challenge, and career development. He emphasizes the significance of treating people well, being authentic, and continuously seeking feedback to grow as a leader. Tune in for a great episode on Leadership, Mentorship and career growth with a phenomenal Pharma leader.

Takeaways 🔑

👌Developing other people is crucial for leadership.

📈The journey from individual contributor to manager can be rapid if the opportunity arises.

👀Observing both good and bad leaders provides valuable lessons.

💞Caring and communication are foundational to effective leadership.

🤝Creating a supportive culture is essential for team success.

📚 Career development should be a priority for leaders.

👨‍🏫 Mentorship can significantly impact career growth.

📑A good mentor is a mentor for life. 

🎉Hiring non-traditional leaders can bring fresh perspectives.

💪Aspiring leaders should treat people well, be themselves, and work hard.

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Article
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
OVN Avatar B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Explore OVN